Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000766322 | SCV000680809 | uncertain significance | not provided | 2016-03-03 | criteria provided, single submitter | clinical testing | The R32X variant in the PON3 gene has not been reported previously as a pathogenic variant nor as a benign variant, to our knowledge. This variant is predicted to cause loss of normal protein function either through protein truncation or nonsense-mediated mRNA decay. The NHLBI ESP Exome Sequencing Project reports R32X was observed in 19/8600 alleles from individuals of European American background, indicating it may be a rare variant in this population; no individuals homozygous for this allele were reported in this control population. We interpret R32X as a variant of uncertain significance. |
Fulgent Genetics, |
RCV000579077 | SCV000895874 | uncertain significance | not specified | 2018-10-31 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000766322 | SCV001115920 | likely benign | not provided | 2019-12-31 | criteria provided, single submitter | clinical testing | |
Suna and Inan Kirac Foundation Neurodegeneration Research Laboratory, |
RCV001095523 | SCV001251104 | likely benign | Amyotrophic lateral sclerosis | 2020-03-31 | criteria provided, single submitter | research |